Recent Updates
Recently added Catalysts
LLY

Lilly Releases Update on Corporate Responsibility Efforts Eli Lilly and Company (NYSE: LLY) has released its 2011/2012 Corporate Responsibility Update (www.lilly.com/Documents/Lilly_2011_2012_CRupdate.pdf)....

Key Takeaway: INDIANAPOLIS , Dec. 3, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY ) has released its 2011/2012 Corporate Responsibility Update ( www.lilly.com/Documents/Lilly_2011_2012_CRupdate.pdf ). This report highlights progress and initiatives since Lilly's 2010/2011 full Corpora

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+45%
120-day peak, hindsight
Typical move
2%
average across 15 past catalysts
Lead asset
Dulaglutide
Phase 3 · Type 2 Diabetes Mellitus

Full Press Release Details

INDIANAPOLIS , Dec. 3, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY ) has released its 2011/2012 Corporate Responsibility Update ( www.lilly.com/Documents/Lilly_2011_2012_CRupdate.pdf ). This report highlights progress and initiatives since Lilly's 2010/2011 full Corporate Responsibility Report. The update, as well as last year's full report, is available on Lilly's website at www.lilly.com .
"Increasingly, we are integrating the concept of 'shared value' into the way we operate," said John C. Lechleiter , Ph.D., Lilly chairman, president and chief executive officer. "Using our business expertise to help address pressing social needs opens up new opportunities for us to provide solutions to health challenges the world over. We believe this approach will help to create enduring value for society and for Lilly. By making individual patients better, we help those patients—as well as their communities and broader societies—to thrive."
Lilly, a leader in advocating for greater transparency by the biopharmaceutical industry, provides a comprehensive report of the company's progress on numerous corporate responsibility goals and efforts. The report includes updates on longstanding programs, as well as data for 2011.
Included in the report are highlights indicating that Lilly:
The Lilly 2011/12 Corporate Responsibility Update also serves as the company's annual Communication on Progress to the United Nations Global Compact (UNGC). As a signatory of the UNGC, Lilly shares its progress annually on 10 principles universally accepted related to human rights, labor, the environment and anti-corruption.
The report details the company's progress in areas such as:
About Eli Lilly and Company
Lilly, a leading innovation-driven corporation is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind. , Lilly provides answers – through medicines and information – for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com . CR-LLY
Last updated: Dec 3, 2012